Bien E
Biomed Biochim Acta. 1983;42(5):561-71.
The pyrazolone derivatives aminophenazone, phenazone, and propyphenazone are capable of decreasing reduced glutathione (GSH) in the liver after a single dose of 3 mmol/kg. The strongest effect is seen in female animals treated with propyphenazone. The depletion can be caused by (1) consumption during phase I of biotransformation, if reactive side products are inactivated by GSH-peroxidase, (2) consumption during phase II of biotransformation, if reactive metabolites are conjugated with GSH by GSH-S-transferases, (3) consumption of NADPH during the biotransformation processes of the pyrazolones as such, (4) influence on enzymes responsible for the synthesis of GSH. After repeated administration only aminophenazone decreases the hepatic content of GSH. Pretreatment with phenobarbital only prevents the propyphenazone-dependent GSH-depletion, but cobaltous chloride has no effect. GSH-depletion is regarded as one of the primary events in liver damage, following pyrazolone administration.
吡唑酮衍生物氨基比林、非那宗和安替比林在单次剂量为3 mmol/kg后能够降低肝脏中的还原型谷胱甘肽(GSH)。在用安替比林治疗的雌性动物中观察到最强的效果。这种消耗可能由以下原因引起:(1)在生物转化的I期消耗,如果反应性副产物被谷胱甘肽过氧化物酶灭活;(2)在生物转化的II期消耗,如果反应性代谢物通过谷胱甘肽S-转移酶与GSH结合;(3)吡唑酮本身在生物转化过程中消耗NADPH;(4)对负责GSH合成的酶的影响。重复给药后,只有氨基比林会降低肝脏中GSH的含量。苯巴比妥预处理仅能防止安替比林依赖性的GSH消耗,但氯化钴没有效果。GSH消耗被认为是吡唑酮给药后肝脏损伤的主要事件之一。